Cargando…
Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513580/ https://www.ncbi.nlm.nih.gov/pubmed/33951399 http://dx.doi.org/10.1164/rccm.202103-0796LE |
| _version_ | 1784583236727341056 |
|---|---|
| author | Burgel, Pierre-Régis Da Silva, Jennifer Paillasseur, Jean-Louis |
| author_facet | Burgel, Pierre-Régis Da Silva, Jennifer Paillasseur, Jean-Louis |
| author_sort | Burgel, Pierre-Régis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8513580 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85135802021-10-14 Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease Burgel, Pierre-Régis Da Silva, Jennifer Paillasseur, Jean-Louis Am J Respir Crit Care Med Correspondence American Thoracic Society 2021-03-30 /pmc/articles/PMC8513580/ /pubmed/33951399 http://dx.doi.org/10.1164/rccm.202103-0796LE Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
| spellingShingle | Correspondence Burgel, Pierre-Régis Da Silva, Jennifer Paillasseur, Jean-Louis Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease |
| title | Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease |
| title_full | Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease |
| title_fullStr | Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease |
| title_full_unstemmed | Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease |
| title_short | Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease |
| title_sort | reply to kuek et al.: optimism with caution: elexacaftor–tezacaftor–ivacaftor in patients with advanced pulmonary disease |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513580/ https://www.ncbi.nlm.nih.gov/pubmed/33951399 http://dx.doi.org/10.1164/rccm.202103-0796LE |
| work_keys_str_mv | AT burgelpierreregis replytokueketaloptimismwithcautionelexacaftortezacaftorivacaftorinpatientswithadvancedpulmonarydisease AT dasilvajennifer replytokueketaloptimismwithcautionelexacaftortezacaftorivacaftorinpatientswithadvancedpulmonarydisease AT paillasseurjeanlouis replytokueketaloptimismwithcautionelexacaftortezacaftorivacaftorinpatientswithadvancedpulmonarydisease |